Prior to joining Medical Capital Group, John was a founder of PrismVentureworks. Prism has six funds, aggregating over $1.25B, and John was responsible for healthcare investing. John is currently on the Board of Directors of Confirma, Inc. MedManage Systems, Uptake Medical and Optiscan of these Prism portfolio companies.

Prior to co-founding Prism, Brooks served as a General Manager at Pfizer/Valleylab where he developed and executed a comprehensive, minimally invasive surgery and emerging opportunity strategy. Prior to that at Pfizer/Strato, he led the growth of a rapidly evolving vascular access medical device business.

Brooks also held several vice president of finance and operations positions at successful high-tech, venture-backed companies and spent over 10 years in public accounting and consulting focused on supporting venture backed entrepreneurs.

Brooks has co-founded three paradigm-shifting life sciences start-ups – Songbird Hearing, Locus Pharmaceuticals and Insulet (PODD).

Brooks is currently a member of the Board of Associates for the Whitehead Institute, is on the Draper BioAdvisory Board, and is the Vice Chair and Finance Chair of the Joslin Diabetes Clinic. John is also a member of MassMedic’s Ignite board, as well as the M2D2 Medical technology initiative.